Huaren Pharmaceuticals: Sodium Lactate Ringer's Injection Passes Consistency Evaluation of Generic Drugs

2026-04-10 06:34:34

People’s Financial News, April 8 — Huaren Pharmaceutical ( 300110 ) announced on April 8 that the company received the “Notification of Approval for the Supplementary Application of the Drug” from the National Medical Products Administration for Sodium Lactate Ringer’s Injection ( Specification: 1000ml ). The drug has passed the consistency evaluation of quality and efficacy for generic drugs. Sodium Lactate Ringer’s Injection is a medication that regulates body fluids, electrolytes, and acid-base balance, suitable for metabolic acidosis or dehydration patients with metabolic acidosis.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes